| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice
|
Plotkin, L.I.
|
|
2011
|
49 |
1 |
p. 122-127
6 p.
|
artikel
|
| 2 |
Announcements
|
|
|
2011
|
49 |
1 |
p. 146-
1 p.
|
artikel
|
| 3 |
Biochemical and molecular mechanisms of action of bisphosphonates
|
Rogers, Michael J.
|
|
2011
|
49 |
1 |
p. 34-41
8 p.
|
artikel
|
| 4 |
Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: What we think we know and what we know that we don't know
|
Allen, Matthew R.
|
|
2011
|
49 |
1 |
p. 56-65
10 p.
|
artikel
|
| 5 |
Bisphosphonates for postmenopausal osteoporosis
|
Eastell, Richard
|
|
2011
|
49 |
1 |
p. 82-88
7 p.
|
artikel
|
| 6 |
Bisphosphonates in oncology
|
Coleman, Robert E.
|
|
2011
|
49 |
1 |
p. 71-76
6 p.
|
artikel
|
| 7 |
Bisphosphonates in orthopedic applications
|
Wilkinson, J. Mark
|
|
2011
|
49 |
1 |
p. 95-102
8 p.
|
artikel
|
| 8 |
Bisphosphonates in Paget's disease
|
Reid, Ian R.
|
|
2011
|
49 |
1 |
p. 89-94
6 p.
|
artikel
|
| 9 |
Bisphosphonates in preclinical bone oncology
|
Clézardin, Philippe
|
|
2011
|
49 |
1 |
p. 66-70
5 p.
|
artikel
|
| 10 |
Bisphosphonates: The first 40years
|
Russell, R. Graham G.
|
|
2011
|
49 |
1 |
p. 2-19
18 p.
|
artikel
|
| 11 |
Editorial Board
|
|
|
2011
|
49 |
1 |
p. i-ii
nvt p.
|
artikel
|
| 12 |
Fluvastatin does not prevent the acute-phase response to intravenous zoledronic acid in post-menopausal women
|
Thompson, Keith
|
|
2011
|
49 |
1 |
p. 140-145
6 p.
|
artikel
|
| 13 |
Foreword: Bisphosphonates
|
Burr, David
|
|
2011
|
49 |
1 |
p. 1-
1 p.
|
artikel
|
| 14 |
Greater magnitude of turnover suppression occurs earlier after treatment initiation with risedronate than alendronate
|
Allen, Matthew R.
|
|
2011
|
49 |
1 |
p. 128-132
5 p.
|
artikel
|
| 15 |
Novel actions of bisphosphonates in bone: Preservation of osteoblast and osteocyte viability
|
Bellido, Teresita
|
|
2011
|
49 |
1 |
p. 50-55
6 p.
|
artikel
|
| 16 |
Pharmacology of bisphosphonates
|
Cremers, Serge
|
|
2011
|
49 |
1 |
p. 42-49
8 p.
|
artikel
|
| 17 |
Risedronate does not reduce mechanical loading-related increases in cortical and trabecular bone mass in mice
|
Sugiyama, Toshihiro
|
|
2011
|
49 |
1 |
p. 133-139
7 p.
|
artikel
|
| 18 |
Safety of bisphosphonates
|
Pazianas, Michael
|
|
2011
|
49 |
1 |
p. 103-110
8 p.
|
artikel
|
| 19 |
The gunmetal mouse reveals Rab geranylgeranyl transferase to be the major molecular target of phosphonocarboxylate analogues of bisphosphonates
|
Coxon, Fraser P.
|
|
2011
|
49 |
1 |
p. 111-121
11 p.
|
artikel
|
| 20 |
The kidney and bisphosphonates
|
Miller, Paul D.
|
|
2011
|
49 |
1 |
p. 77-81
5 p.
|
artikel
|
| 21 |
The relationship between the chemistry and biological activity of the bisphosphonates
|
Ebetino, Frank H.
|
|
2011
|
49 |
1 |
p. 20-33
14 p.
|
artikel
|
Tijdschrift beschrijving